Fluidigm among First Seven Companies to Advance in Historic and Rapidly Instituted Program to Support Development and Commercialization of Innovative COVID-19 Testing Technologies

SOUTH SAN FRANCISCO, Calif. -- Fluidigm Corporation (Nasdaq:FLDM), an innovative biotechnology tools provider with a vision to improve life through comprehensive health insight, today announced execution of a letter contract with the National Institutes of Health, National Institute of Biomedical Imaging and Bioengineering, for a proposed project under the agency’s Rapid Acceleration of Diagnostics (RADx) [...]

Launch of a New Spike-In RNA Variant Module with 4 – 12 kb long RNAs

Today we launched the Long SIRV module. The long SIRVs are the latest addition to the Spike-In RNA Variants (SIRVs), Lexogen’s portfolio of external RNA reference standards. The 15 RNAs in this module cover the five length categories of 4 kb, 6 b, 8 kb, 10 kb, and 12 kb, each represented by three unique transcripts. [...]

Corning Adds 3D Clear Tissue Clearing Reagent to its 3D Cell Culture Imaging Portfolio

Corning’s new tissue clearing technology is designed for in vitro 3D cell culture models such as spheroids, organoids, and microtissues. Corning Incorporated (NYSE: GLW) today announced the launch of its 3D Clear Tissue Clearing Reagent, allowing for rapid and easy imaging of tissues in 3D cell culture without damaging the underlying cellular morphology. This solution, manufactured [...]

Fluidigm Selected for $37 Million Project under National Institutes of Health RADx Initiative

Fluidigm among First Seven Companies to Advance in Historic and Rapidly Instituted Program to Support Development and Commercialization of Innovative COVID-19 Testing Technologies SOUTH SAN FRANCISCO, Calif. -- Fluidigm Corporation (Nasdaq:FLDM), an innovative biotechnology tools provider with a vision to improve life through comprehensive health insight, today announced execution of a letter contract with the [...]

USDA-FGIS Approves Renewal and Awards 5-Year Contract for Aflatoxin Test to Charm Sciences

FGIS's aflatoxin testing program to renew usage of Charm's Water Extraction Technology, as well as award contract for five years. LAWRENCE, Mass.-- Charm Sciences, Inc. announces that the United States Department of Agriculture's Federal Grain Inspection Service (USDA-FGIS) has renewed the usage of the ROSA® WET®-S5 Aflatoxin Quantitative Test. This lateral flow test was first approved in [...]

LUMICKS enters collaboration with Glycostem to enhance NK cell-mediated immunotherapy

Amsterdam, the Netherlands, Oss, the Netherlands —  LUMICKS has entered into a collaboration with Glycostem Therapeutics, the Netherlands, to improve immunotherapeutic drug development. By quantifying binding strength between immune and cancer cells using the unique z-Movi® Cell Avidity Analyzer, Glycostem exploits the predictiveness of avidity in finding the best NK-cell population for cellular therapy. Glycostem [...]

Agilent Introduces Solutions to Simplify Cannabis and Hemp Potency and Pesticide/Mycotoxin Testing

Innovative online tool, and new consumables kits provide pioneering solutions for faster set up and analysis Santa Clara -- Agilent Technologies Inc. (NYSE: A) today announced solutions for the fast-growing cannabis and hemp testing market. The new Agilent eMethods product, as well as the Cannabis and Hemp Potency Kit and the Cannabis Pesticide and Mycotoxin Kit, offer testing labs [...]

COVID-19 : RESEARCH PARTNERSHIP BETWEEN PHYTRONIX, UNIVERSITÉ DE SHERBROOKE AND UNIVERSITÉ DE MONTRÉAL

COVID-19: A Method to TestMore… and Better! ANALYZING 30,000 SAMPLES PER DAY FOR COVID-19 : THAT IS WHAT RESEARCH TEAMS FROM THE UNIVERSITÉ DE SHERBROOKE AND THE UNIVERSITÉ DE MONTRÉAL ARE WORKING ON ATTAINING. The research teams hope to improve the screening for COVID-19 using a technology patented, developed and manufactured in Quebec, by Phytronix. [...]

Diagenode and Alithea Genomics collaborate to offer scalable and affordable RNA-seq services

Diagenode expands services offering by introducing new high-throughput 3’mRNA sequencing service that utilizes MERCURIUS technology Diagenode, a leading global provider of solutions for epigenetics research and sample preparation, has partnered with Alithea Genomics to provide a novel low cost, high performance 3’ mRNA-seq service to help advance transcriptomics research. The new Alithea-powered technology, known as “MERCURIUS”, enables reliable [...]

HTG Expands RUO Profiling Menu with New NGS Platform Capability Assays

Entire HTG RUO profiling assay menu now available for use on both Illumina’s and Thermo Fisher Scientific’s NGS platform TUCSON, Ariz. -- HTG Molecular Diagnostics, Inc. (Nasdaq: HTGM) (HTG), a life science company whose mission is to advance precision medicine, today announced three of its previously released Research Use Only (RUO) assays are now available [...]

Access IBO on Knowledge Center